Home » Topics » BioWorld Science

BioWorld Science
RSS

Mirati Therapeutics synthesizes new SOS1 inhibitors

Feb. 23, 2022

New IRAK and FLT3 inhibitors described by U.S. investigators

Feb. 23, 2022

Columbia University discloses CD33/CD45 interaction inhibitors

Feb. 23, 2022

U.S. researchers divulge CDK19 inhibitors

Feb. 23, 2022

Ideaya Biosciences presents POLQ inhibitors

Feb. 23, 2022

Discovery of novel peptides as probes for crotamine

Feb. 23, 2022

S-05014, a novel tyrosinase inhibitor with promising anti-Parkinsonian activity

Feb. 23, 2022

MZE-001 shows promising results in murine and canine models of Pompe disease

Feb. 23, 2022

Blockade of HIF-1 leads to ROS overproduction in diabetes

Feb. 23, 2022

Engineered Wnt ligands repair BBB in neuro disorders

Feb. 22, 2022

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.